Fibroblast-like synoviocytes (FLSs) in the synovium of patients with RA can promote cartilage and bone destruction by producing matrix metalloproteinases and receptor activators of NF-κB ligands, thereby representing an important therapeutic target for RA. Here, NFKB1 is linked to rheumatoid arthritis.